NEW YORK (GenomeWeb News) - TriPath Imaging said today that it has signed a definitive merger agreement with Becton, Dickinson, under which BD will acquire the 93.5 percent of outstanding TriPath shares that it does not currently own in a deal worth approximately $350 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.